United Therapeutics Corporation (NASDAQ:UTHR) Q3 2024 Earnings Call Transcript
United Therapeutics Corporation (NASDAQ:UTHR) Q3 2024 Earnings Call Transcript October 30, 2024United Therapeutics Corporation misses on earnings expectations.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | VenBio Select Advisor Kurt Von Emster | 2,858,888 | $910,698,772 | 12.12% | |
2. | Renaissance Technologies Jim Simons | 2,174,692 | $692,748,137 | +2% | 1.17% |
3. | AQR Capital Management Cliff Asness | 719,510 | $229,199,910 | -16% | 0.35% |
4. | Palo Alto Investors William Leland Edwards | 266,914 | $85,025,455 | -1% | 9.85% |
5. | Eversept Partners Kamran Moghtaderi | 235,351 | $74,971,061 | -7% | 5.13% |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$82.83 | 4 | Director | 1,684 | 2019-06-10 | Filing | |
$114.06 | 6 | Director | 1,686 | 2018-04-20 | Filing | |
$126.20 | 5 | Director | 1,685 | 2017-11-20 | Filing | |
$128.35 | 3 | Director | 1,686 | 2017-07-28 | Filing | |
$130.24 | 3 | Director | 1,683 | 2017-07-17 | Filing |
Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
---|---|---|---|---|---|---|
$350.00 | 576 | 7,512 | 2024-10-28 | Filing | ||
$350.00 | 557 | 7,238 | 2024-10-28 | Filing | ||
$350.00 | 3,400 | 6,978 | 2024-10-28 | Filing | ||
$350.00 | 3,267 | 6,978 | 2024-10-28 | Filing | ||
$366.99 | 567 | 6,978 | 2024-10-21 | Filing |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 5,295,000 | $1,164,317,551 | 0.02% | |
2. | 4,673,678 | $1,027,695,057 | 0.02% | |
3. | 3,794,010 | $834,264,860 | 0.15% | |
4. | 2,321,040 | $510,373,376 | 0.03% | |
5. | 1,947,177 | $428,164,751 | 0.02% |